Cardinal Health, Inc. (NYSE:CAH) Shares Sold by KMG Fiduciary Partners LLC

KMG Fiduciary Partners LLC decreased its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 26.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 58,467 shares of the company's stock after selling 21,510 shares during the quarter. KMG Fiduciary Partners LLC's holdings in Cardinal Health were worth $8,055,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the stock. Geode Capital Management LLC raised its position in Cardinal Health by 1.9% in the 4th quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company's stock worth $691,145,000 after purchasing an additional 109,273 shares during the period. Invesco Ltd. raised its holdings in shares of Cardinal Health by 4.6% in the fourth quarter. Invesco Ltd. now owns 3,182,514 shares of the company's stock worth $376,396,000 after buying an additional 140,368 shares during the period. Marshall Wace LLP lifted its stake in shares of Cardinal Health by 154.6% during the 4th quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock worth $372,756,000 after acquiring an additional 1,913,892 shares during the last quarter. Northern Trust Corp boosted its holdings in Cardinal Health by 16.2% during the 4th quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock valued at $359,286,000 after acquiring an additional 422,755 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Cardinal Health by 4.3% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock valued at $274,599,000 after acquiring an additional 94,768 shares during the last quarter. Institutional investors own 87.17% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Morgan Stanley lifted their target price on Cardinal Health from $142.00 to $166.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Wall Street Zen upgraded shares of Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Monday, May 5th. Mizuho boosted their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Wells Fargo & Company raised shares of Cardinal Health from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Finally, UBS Group boosted their price target on Cardinal Health from $150.00 to $160.00 and gave the company a "buy" rating in a report on Tuesday, April 29th. Three research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Cardinal Health currently has a consensus rating of "Moderate Buy" and an average price target of $149.50.

Cardinal Health Price Performance

NYSE CAH traded down $1.09 during midday trading on Monday, hitting $153.62. 245,177 shares of the company traded hands, compared to its average volume of 2,211,340. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $157.82. The company's 50-day simple moving average is $143.52 and its 200-day simple moving average is $131.57. The company has a market cap of $36.67 billion, a PE ratio of 28.66, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The company had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The firm's revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter last year, the company earned $2.08 earnings per share. On average, research analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.33%. The ex-dividend date is Tuesday, July 1st. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's payout ratio is 31.83%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.